Cargando…

Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists

BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, am...

Descripción completa

Detalles Bibliográficos
Autores principales: Picco, Louisa, Lam, Tina, Xia, Ting, Nielsen, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759276/
https://www.ncbi.nlm.nih.gov/pubmed/36528707
http://dx.doi.org/10.1007/s11096-022-01523-3
_version_ 1784852196522721280
author Picco, Louisa
Lam, Tina
Xia, Ting
Nielsen, Suzanne
author_facet Picco, Louisa
Lam, Tina
Xia, Ting
Nielsen, Suzanne
author_sort Picco, Louisa
collection PubMed
description BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, among a representative sample of community pharmacists in Victoria, Australia. METHOD: An online anonymous survey was conducted and collected data in relation to pharmacist and pharmacy characteristics, comfort in performing certain tasks, PDMP training and the frequency of PDMP use under voluntary and mandatory conditions. Multivariate logistic regression models were performed to determine the effect of each covariate on voluntary and mandatory PDMP use. RESULTS: In total, 265 pharmacists participated (response rate 47%). Under voluntary conditions, a quarter of pharmacists (24.9%) used the PDMP all the time, while half (51.7%) used the PDMP all of the time, once mandated. Pharmacies that stocked naloxone (OR: 1.96; 95% CI 1.11–3.45) and pharmacists that had attended formal PDMP training (OR: 1.78; 95% CI 1.05–3.05), were significantly associated with regular PDMP use under voluntary conditions. Under mandatory conditions, increased odds of PDMP use were associated with pharmacies that stocked naloxone (OR: 1.88; 95% CI 1.06–3.34). Pharmacists working in regional and rural areas had significantly lower odds (OR: 0.35; 95% CI 0.20–0.63) of always using the PDMP, as did pharmacists with > 15 years’ experience (OR: 0.24; 95% CI 0.11–0.51) once use was mandated. CONCLUSION: Given that PDMP utilisation was slower or less regular amongst pharmacists located in regional and rural areas, pharmacists with more years of experience and those not already supplying naloxone, targeted training aimed at these sub-populations may be beneficial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01523-3.
format Online
Article
Text
id pubmed-9759276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-97592762022-12-19 Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists Picco, Louisa Lam, Tina Xia, Ting Nielsen, Suzanne Int J Clin Pharm Research Article BACKGROUND: Prescription drug monitoring programs (PDMP) are databases which collect prescribing and dispensing information for high-risk medicines, and are one approach to mitigate prescription opioid-related risks. AIM: To examine correlates of PDMP use under voluntary and mandatory conditions, among a representative sample of community pharmacists in Victoria, Australia. METHOD: An online anonymous survey was conducted and collected data in relation to pharmacist and pharmacy characteristics, comfort in performing certain tasks, PDMP training and the frequency of PDMP use under voluntary and mandatory conditions. Multivariate logistic regression models were performed to determine the effect of each covariate on voluntary and mandatory PDMP use. RESULTS: In total, 265 pharmacists participated (response rate 47%). Under voluntary conditions, a quarter of pharmacists (24.9%) used the PDMP all the time, while half (51.7%) used the PDMP all of the time, once mandated. Pharmacies that stocked naloxone (OR: 1.96; 95% CI 1.11–3.45) and pharmacists that had attended formal PDMP training (OR: 1.78; 95% CI 1.05–3.05), were significantly associated with regular PDMP use under voluntary conditions. Under mandatory conditions, increased odds of PDMP use were associated with pharmacies that stocked naloxone (OR: 1.88; 95% CI 1.06–3.34). Pharmacists working in regional and rural areas had significantly lower odds (OR: 0.35; 95% CI 0.20–0.63) of always using the PDMP, as did pharmacists with > 15 years’ experience (OR: 0.24; 95% CI 0.11–0.51) once use was mandated. CONCLUSION: Given that PDMP utilisation was slower or less regular amongst pharmacists located in regional and rural areas, pharmacists with more years of experience and those not already supplying naloxone, targeted training aimed at these sub-populations may be beneficial. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11096-022-01523-3. Springer International Publishing 2022-12-17 2023 /pmc/articles/PMC9759276/ /pubmed/36528707 http://dx.doi.org/10.1007/s11096-022-01523-3 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Article
Picco, Louisa
Lam, Tina
Xia, Ting
Nielsen, Suzanne
Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title_full Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title_fullStr Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title_full_unstemmed Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title_short Factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
title_sort factors associated with prescription drug monitoring program utilisation: a cross-sectional survey of community pharmacists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759276/
https://www.ncbi.nlm.nih.gov/pubmed/36528707
http://dx.doi.org/10.1007/s11096-022-01523-3
work_keys_str_mv AT piccolouisa factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists
AT lamtina factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists
AT xiating factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists
AT nielsensuzanne factorsassociatedwithprescriptiondrugmonitoringprogramutilisationacrosssectionalsurveyofcommunitypharmacists